Quantcast

Latest Neuroblastoma Stories

2011-12-13 12:14:03

A large, retrospective study shows that children of childhood cancer survivors who received prior treatment involving radiation to testes or ovaries and/or chemotherapy with alkylating agents do not have an increased risk for birth defects compared to children of survivors who did not have such cancer treatment. The findings provide reassurance that increased risks of birth defects are unlikely for cancer survivors who are concerned about the potential effects of their treatment on their...

2011-10-19 19:15:59

Two Baylor College of Medicine physicians have received support from the nonprofit group Cookies for Kids' Cancer for their research on neuroblastoma — a common type of solid tumor in children. Dr. Leonid Metelitsa, associate professor of pediatrics at BCM and a pediatric oncologist at Texas Children's Cancer Center, and Dr. Jed Nuchtern, professor of pediatrics and of surgery at BCM, who is a surgical oncologist at the center, each received $100,000 from the organization. The...

2011-09-19 23:49:08

Poorer treatment outcomes Patients with a high degree of African ancestry had a greater incidence of high-risk neuroblastoma and poorer outcomes, according to preliminary results presented here at the Fourth AACR Conference on The Science of Cancer Health Disparities, held here Sept. 18-21, 2011. "There are common genetic variants that are associated with the development of high-risk neuroblastoma and a poor outcome," said Navin R. Pinto, M.D., instructor of pediatrics at the University...

2011-06-30 13:46:02

A new treatment option may soon be available for children with neuroblastoma according to research published in the July issue of The Journal of Nuclear Medicine. The study tested the principle that combined positron emission tomography and X-ray computed tomography (PET/CT) may be used to select children with primary refractory or relapsed high-risk neuroblastoma for treatment with a molecular radiotherapy known as 177Lu-DOTATATE. This therapeutic option was found to be viable option for...

2011-06-22 10:00:00

VIENNA, June 22, 2011 /PRNewswire/ -- Vienna based biotech company APEIRON Biologics AG (Apeiron) strengthens its oncology pipeline: The company will support the clinical development of an immune therapy against high-risk neuroblastoma that is being conducted by the Children's Cancer Research Institute (CCRI) and the European Neuroblastoma Research Network (SIOPEN). It is presently under investigation in a phase III trial across various European clinical centers. In return,...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related